Company Profiles

driven by the PitchBook Platform

Avacen

Avacen
PRIVATE STATUS
11-50 EMPLOYEES
Angel LATEST DEAL TYPE
$2M LATEST DEAL AMOUNT
$4.9M TOTAL AMOUNT RAISED
Description

Developer of medical devices and drugs to treat pain associated diseases. The company develops noninvasive drug free alternatives to treat pain associated with diseases such as arthritis, fibromyalgia and migraines.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Drug Discovery
Primary Office
7920 Silverton Avenue
Suite L
San Diego, CA 92126
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avacen’s full profile, request a free trial.

Avacen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Feb-2015 $2M $4.9M Completed Startup
3. Angel (individual) 01-Oct-2014 00.000 00.00 Completed Startup
2. Angel (individual) 01-Dec-2012 $1.31M $1.61M Completed Startup
1. Angel (individual) 01-Dec-2010 $295k $295k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Avacen Executive Team (1)

Name Title Board
Seat
Contact
Info
Thomas Muehlbauer Founder, President, Chief Executive Officer & Board Member

Avacen Board Members (9)

Name Representing Role Since Contact
Info
Don Miller Avacen Board Member 000 0000
Gary Pace Ph.D Avacen Board Member 000 0000
James Wangler Avacen Board Member 000 0000
Jonathan Lakey Ph.D Avacen Board Member 000 0000
Judith Swain MD Avacen Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »